Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 03-Sep-24 6:10 PM View:  | Malik Aamir Executive Vice President | Pfizer Inc. (PFE) | 31-Aug-24 | Payment of Exercise | 20,195 | $29.01 | $585,857.00 | (41%) 49.74K to 29.55K | |
| 14-Aug-24 3:47 PM View: | Damico Jennifer B. SVP & Controller | Pfizer Inc. (PFE) | 13-Aug-24 | Sale | 5,154 | $28.66 | $147,714.00 | (38%) 13.74K to 8.58K | |
| 03-Jun-24 6:34 PM View: | Denton David M Chief Financial Officer & EVP | Pfizer Inc. (PFE) | 31-May-24 | Payment of Exercise | 12,107 | $28.66 | $346,987.00 | (24%) 50.03K to 37.92K | |
| 29-Feb-24 6:53 AM View: | Dolsten Mikael President R&D | Pfizer Inc. (PFE) | 28-Feb-24 | Payment of Exercise | 21,437 | $27.04 | $579,656.00 | (6%) 345.15K to 323.71K | |
| 01-Mar-24 1:28 PM View: | Boshoff Christoffel Executive Vice President | Pfizer Inc. (PFE) | 28-Feb-24 | Grant | 11,510 | -- | -- | 8% 149.27K to 160.78K | |
| 01-Mar-24 1:28 PM View: | Boshoff Christoffel Executive Vice President | Pfizer Inc. (PFE) | 28-Feb-24 | Payment of Exercise | 4,150 | $27.04 | $112,216.00 | (3%) 160.78K to 156.63K | |
| 28-Feb-24 10:00 PM View: | de Germay Alexandre Executive Vice President | Pfizer Inc. (PFE) | 27-Feb-24 | Grant | 74,377 | -- | -- | 100% 0 to 74.38K | |
| 28-Feb-24 4:58 PM View: | Damico Jennifer B. SVP & Controller | Pfizer Inc. (PFE) | 27-Feb-24 | Grant | 5,113 | -- | -- | 61% 8.38K to 13.49K | |
| 27-Feb-24 1:47 PM View: | McDermott Michael Executive Vice President | Pfizer Inc. (PFE) | 26-Feb-24 | Payment of Exercise | 6,063 | $27.18 | $164,792.00 | (7%) 81.53K to 75.46K | |
| 27-Feb-24 1:44 PM View: | Boshoff Christoffel Executive Vice President | Pfizer Inc. (PFE) | 25-Feb-24 | Grant | 15,455 | -- | -- | 11% 140.01K to 155.47K | |
| 27-Feb-24 1:47 PM View: | McDermott Michael Executive Vice President | Pfizer Inc. (PFE) | 25-Feb-24 | Payment of Exercise | 2,992 | $27.76 | $83,057.90 | (4%) 84.52K to 81.53K | |
| 27-Feb-24 1:44 PM View: | Boshoff Christoffel Executive Vice President | Pfizer Inc. (PFE) | 25-Feb-24 | Payment of Exercise | 6,197 | $27.76 | $172,029.00 | (4%) 155.47K to 149.27K | |
| 27-Feb-24 1:46 PM View: | Damico Jennifer B. SVP & Controller | Pfizer Inc. (PFE) | 25-Feb-24 | Payment of Exercise | 1,386 | $27.76 | $38,475.40 | (14%) 9.77K to 8.38K | |
| 27-Feb-24 1:44 PM View: | Boshoff Christoffel Executive Vice President | Pfizer Inc. (PFE) | 24-Feb-24 | Payment of Exercise | 300 | $27.76 | $8,328.00 | (< 1%) 140.31K to 140.01K | |
| 27-Feb-24 1:46 PM View: | Damico Jennifer B. SVP & Controller | Pfizer Inc. (PFE) | 24-Feb-24 | Payment of Exercise | 354 | $27.76 | $9,827.04 | (3%) 10.12K to 9.77K | |
| 27-Feb-24 1:46 PM View: | Susman Sally Executive Vice President | Pfizer Inc. (PFE) | 23-Feb-24 | Payment of Exercise | 56,537 | $27.40 | $1,549,350.00 | (26%) 218.96K to 162.42K | |
| 27-Feb-24 1:47 PM View: | McDermott Michael Executive Vice President | Pfizer Inc. (PFE) | 23-Feb-24 | Payment of Exercise | 10,890 | $27.40 | $298,394.00 | (11%) 95.41K to 84.52K | |
| 27-Feb-24 1:47 PM View: | McDermott Michael Executive Vice President | Pfizer Inc. (PFE) | 23-Feb-24 | Option Exercise | 12,412 | $27.34 | $339,344.00 | 15% 83.0K to 95.41K | |
| 27-Feb-24 1:46 PM View: | Sahni Payal Executive Vice President | Pfizer Inc. (PFE) | 23-Feb-24 | Payment of Exercise | 10,219 | $27.40 | $280,047.00 | (22%) 46.01K to 35.79K | |
| 27-Feb-24 1:44 PM View: | Boshoff Christoffel Executive Vice President | Pfizer Inc. (PFE) | 23-Feb-24 | Option Exercise | 9,752 | $27.34 | $266,620.00 | 7% 139.57K to 149.33K | |
| 27-Feb-24 1:46 PM View: | Damico Jennifer B. SVP & Controller | Pfizer Inc. (PFE) | 23-Feb-24 | Payment of Exercise | 9,106 | $27.42 | $249,709.00 | (47%) 19.23K to 10.12K | |
| 27-Feb-24 1:46 PM View: | Johnson Rady A Executive Vice President | Pfizer Inc. (PFE) | 23-Feb-24 | Option Exercise | 29,436 | $27.34 | $804,780.00 | 29% 99.94K to 129.37K | |
| 27-Feb-24 1:46 PM View: | Bourla Albert Chairman & CEO Director | Pfizer Inc. (PFE) | 23-Feb-24 | Option Exercise | 127,674 | $27.34 | $3,490,610.00 | 40% 316.82K to 444.5K | |
| 27-Feb-24 1:46 PM View: | Damico Jennifer B. SVP & Controller | Pfizer Inc. (PFE) | 23-Feb-24 | Option Exercise | 9,752 | $27.34 | $266,620.00 | 103% 9.48K to 19.23K | |
| 27-Feb-24 1:46 PM View: | Susman Sally Executive Vice President | Pfizer Inc. (PFE) | 23-Feb-24 | Option Exercise | 63,837 | $27.34 | $1,745,300.00 | 41% 155.12K to 218.96K | |
| 27-Feb-24 1:46 PM View: | Sahni Payal Executive Vice President | Pfizer Inc. (PFE) | 23-Feb-24 | Option Exercise | 11,527 | $27.34 | $315,148.00 | 33% 34.48K to 46.01K | |
| 27-Feb-24 1:46 PM View: | Lankler Douglas M Executive Vice President | Pfizer Inc. (PFE) | 23-Feb-24 | Payment of Exercise | 84,002 | $27.40 | $2,301,720.00 | (36%) 232.75K to 148.75K | |
| 27-Feb-24 1:44 PM View: | Boshoff Christoffel Executive Vice President | Pfizer Inc. (PFE) | 23-Feb-24 | Payment of Exercise | 9,014 | $27.42 | $247,155.00 | (6%) 149.33K to 140.31K | |
| 27-Feb-24 1:46 PM View: | Lankler Douglas M Executive Vice President | Pfizer Inc. (PFE) | 23-Feb-24 | Option Exercise | 95,755 | $27.34 | $2,617,940.00 | 70% 137.0K to 232.75K | |
| 27-Feb-24 1:46 PM View: | Johnson Rady A Executive Vice President | Pfizer Inc. (PFE) | 23-Feb-24 | Payment of Exercise | 25,920 | $27.40 | $710,262.00 | (20%) 129.37K to 103.45K | |
| 27-Feb-24 1:46 PM View: | Bourla Albert Chairman & CEO Director | Pfizer Inc. (PFE) | 23-Feb-24 | Payment of Exercise | 112,009 | $27.40 | $3,069,130.00 | (25%) 444.5K to 332.49K | |
| 27-Feb-24 1:46 PM View: | Dolsten Mikael President R&D | Pfizer Inc. (PFE) | 23-Feb-24 | Payment of Exercise | 24,822 | $27.76 | $689,059.00 | (7%) 369.97K to 345.15K | |
| 29-Dec-23 6:05 PM View: | Boshoff Christoffel Executive Vice President | Pfizer Inc. (PFE) | 29-Dec-23 | Grant | 34,734 | -- | -- | 34% 103.18K to 137.91K | |
| 19-Dec-23 9:31 AM View: | Gottlieb Scott Director | Pfizer Inc. (PFE) | 15-Dec-23 | Private Purchase | 3,000 | $26.47 | $79,401.00 | 50% 6.0K to 9.0K | |
| 01-Jun-23 4:06 PM View: | Denton David M Chief Financial Officer & EVP | Pfizer Inc. (PFE) | 31-May-23 | Payment of Exercise | 16,223 | $38.02 | $616,798.00 | (25%) 64.45K to 48.22K | |
| 09-May-23 4:17 PM View: | Gottlieb Scott Director | Pfizer Inc. (PFE) | 08-May-23 | Purchase | 1,000 | $38.58 | $38,580.00 | 20% 5.0K to 6.0K | |
| 09-May-23 4:17 PM View: | Gottlieb Scott Director | Pfizer Inc. (PFE) | 05-May-23 | Private Purchase | 1,000 | $38.42 | $38,425.00 | 25% 4.0K to 5.0K | |
| 03-Apr-23 6:23 PM View: | Pao William Executive Vice President | Pfizer Inc. (PFE) | 31-Mar-23 | Payment of Exercise | 22,095 | $40.80 | $901,476.00 | (18%) 119.86K to 97.77K | |
| 17-Mar-23 4:53 PM View: | Damico Jennifer B. SVP & Controller | Pfizer Inc. (PFE) | 15-Mar-23 | Sale | 9,912 | $40.02 | $396,678.00 | (52%) 18.91K to 9.0K | |
| 28-Feb-23 10:00 PM View: | Sahni Payal Executive Vice President | Pfizer Inc. (PFE) | 27-Feb-23 | Payment of Exercise | 1,297 | $40.78 | $52,891.70 | (4%) 34.75K to 33.45K | |
| 28-Feb-23 5:52 PM View: | Damico Jennifer B. SVP & Controller | Pfizer Inc. (PFE) | 27-Feb-23 | Payment of Exercise | 1,427 | $40.78 | $58,193.10 | (7%) 20.7K to 19.27K | |
| 28-Feb-23 5:52 PM View: | McDermott Michael Executive Vice President | Pfizer Inc. (PFE) | 27-Feb-23 | Payment of Exercise | 3,081 | $40.78 | $125,643.00 | (4%) 83.95K to 80.87K | |
| 28-Feb-23 5:52 PM View: | Hwang Angela President, Global Biopharma | Pfizer Inc. (PFE) | 25-Feb-23 | Payment of Exercise | 14,763 | $42.78 | $631,591.00 | (18%) 81.92K to 67.16K | |
| 28-Feb-23 5:52 PM View: | Damico Jennifer B. SVP & Controller | Pfizer Inc. (PFE) | 25-Feb-23 | Option Exercise | 11,150 | $22.89 | $255,224.00 | 67% 16.74K to 27.89K | |
| 28-Feb-23 8:24 AM View: | Bourla Albert Chairman & CEO Director | Pfizer Inc. (PFE) | 25-Feb-23 | Payment of Exercise | 43,419 | $41.75 | $1,812,740.00 | (12%) 356.76K to 313.34K | |
| 28-Feb-23 5:52 PM View: | Hwang Angela President, Global Biopharma | Pfizer Inc. (PFE) | 25-Feb-23 | Option Exercise | 20,273 | $22.89 | $464,049.00 | 33% 61.65K to 81.92K | |
| 28-Feb-23 5:52 PM View: | Johnson Rady A Executive Vice President | Pfizer Inc. (PFE) | 25-Feb-23 | Option Exercise | 33,654 | $22.89 | $770,340.00 | 38% 88.79K to 122.45K | |
| 28-Feb-23 8:24 AM View: | Dolsten Mikael President R&D | Pfizer Inc. (PFE) | 25-Feb-23 | Payment of Exercise | 37,078 | $41.75 | $1,548,010.00 | (9%) 393.1K to 356.03K | |
| 28-Feb-23 5:52 PM View: | McDermott Michael Executive Vice President | Pfizer Inc. (PFE) | 25-Feb-23 | Payment of Exercise | 9,144 | $42.92 | $392,417.00 | (10%) 93.1K to 83.95K | |
| 28-Feb-23 5:52 PM View: | Susman Sally Executive Vice President | Pfizer Inc. (PFE) | 25-Feb-23 | Option Exercise | 72,984 | $22.89 | $1,670,600.00 | 53% 136.97K to 209.95K |
